Dental Membrane and Bone Graft Substitutes Market Players:
- Dentsply Sirona
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Straumann AG
- Zimmer Biomet Inc.
- Biohorizons Inc
- Geistlich Pharma Ag
- Rti Surgicals
- Dentium Co, Ltd.
- Lifenet Health
- Medtronic plc
- Orthogen AG
The dental membrane and bone graft substitutes market companies are engaging in several ongoing trends, including development of bioresorbable membranes and synthetic bone graft substitutes that promote natural bone regeneration while minimizing surgical interventions. Companies are also investing in regenerative medicine-based products, such as growth-factor-infused membranes, to improve clinical outcomes. Some of the companies participating in the market include:
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of dental membrane and bone graft substitutes is estimated at USD 1.07 billion.
The global dental membrane and bone graft substitutes market size was around USD 988.46 million in 2025 and is likely to expand at a CAGR of more than 9.2%, surpassing USD 2.38 billion revenue by 2035.
North America’s dental membrane and bone graft substitutes market will secure around 37% share by 2035, driven by increased dental visits, aging population, and use of bone graft substitutes.
Key players in the market include Dentsply Sirona, Straumann AG, Zimmer Biomet Inc., Biohorizons Inc, Geistlich Pharma Ag, Rti Surgicals, Dentium Co, Ltd., Lifenet Health, Medtronic plc, Orthogen AG.
